We are live on ! Find out more
ASXC

Asensus Surgical, Inc.

Delisted

ASXC was delisted on the 21st of August, 2024.

67 hedge funds and large institutions have $31.4M invested in Asensus Surgical, Inc. in 2017 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 22 increasing their positions, 16 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

182% more call options, than puts

Call options by funds: $158K | Put options by funds: $56K

38% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 16

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

16% less funds holding

Funds holding: 8067 (-13)

33% less capital invested

Capital invested by funds: $47M → $31.4M (-$15.6M)

59% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 22

Holders
67
Holders Change
-13
Holders Change %
-16.25%
% of All Funds
1.67%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.07%
New
9
Increased
22
Reduced
16
Closed
22
Calls
$158K
Puts
$56K
Net Calls
+$102K
Net Calls Change
+$89K
Name Holding Trade Value Shares
Change
Change in
Stake
AC
1
Aisling Capital
New York
$7.34M +$1.46M +153,846 +24%
SHI
2
SV Health Investors
Massachusetts
$5.36M
JP Morgan Chase
3
JP Morgan Chase
New York
$3M +$2.03K +213 +0.1%
MCM
4
Masters Capital Management
Georgia
$2.84M +$1.54M +161,629 +111%
SM
5
Sabby Management
Florida
$2.46M +$2.53M +266,103 New
SG
6
StepStone Group
California
$2.15M
Vanguard Group
7
Vanguard Group
Pennsylvania
$1.53M -$194K -20,445 -11%
CS
8
Credit Suisse
Switzerland
$857K +$868K +91,239 +5,553%
Goldman Sachs
9
Goldman Sachs
New York
$854K +$868K +91,275 +7,136%
Millennium Management
10
Millennium Management
New York
$671K +$521K +54,817 +307%
IBT
11
International Biotechnology Trust
United Kingdom
$625K
UOC
12
UBS O'Connor
Illinois
$390K +$402K +42,261 New
BlackRock
13
BlackRock
New York
$380K -$2.33M -245,219 -86%
Royal Bank of Canada
14
Royal Bank of Canada
Ontario, Canada
$298K +$44.7K +4,695 +17%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$279K -$82.4K -8,659 -22%
ECM
16
Element Capital Management
New York
$269K +$277K +29,108 New
GXMC
17
Global X Management Company
New York
$235K +$171K +17,939 +238%
LP
18
LMR Partners
United Kingdom
$189K +$195K +20,466 New
PP
19
Paloma Partners
Connecticut
$183K +$189K +19,831 New
Northern Trust
20
Northern Trust
Illinois
$119K -$384K -40,416 -76%
NPC
21
National Planning Corporation
California
$118K -$5.85K -615 -4%
Susquehanna International Group
22
Susquehanna International Group
Pennsylvania
$116K +$120K +12,597 New
California Public Employees Retirement System
23
California Public Employees Retirement System
California
$115K
AQR Capital Management
24
AQR Capital Management
Connecticut
$110K -$276K -29,059 -71%
Deutsche Bank
25
Deutsche Bank
Germany
$84K +$75.5K +7,935 +607%

ASXC Hedge Fund Activity: Q2 2017 in Review

67 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Asensus Surgical, Inc. (ASXC) for Q2 2017, worth a combined $31.4M — down 33% from $47M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of ASXC and 9 opened new positions — a net loss of 13 holders — while 16 trimmed existing stakes and 22 added.

The largest buyer was Sabby Management, opening a new position worth an estimated $2.53M. The largest seller was BlackRock, cutting an estimated $2.33M.

  • 67 institutional investors held Asensus Surgical, Inc. (ASXC) as of Q2 2017, down from 80 in Q1 2017.
  • Funds reported $31.4M of Asensus Surgical, Inc. stock for Q2 2017, down 33% quarter-over-quarter.
  • 9 funds opened new Asensus Surgical, Inc. positions in Q2 2017 and 22 closed out, a net change of -13 holders.
  • The largest Asensus Surgical, Inc. buyer in Q2 2017 was Sabby Management, an estimated $2.53M added.
  • The largest Asensus Surgical, Inc. seller in Q2 2017 was BlackRock, an estimated $2.33M sold.

Based on aggregated 13F filings for Q2 2017.